These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12920629)

  • 1. Longitudinal analysis of intermediate outcomes in adolescent hemodialysis patients.
    Neu AM; Fivush BA; Warady BA; Watkins SL; Friedman AL; Brem AS; Goldstein S; Frankenfield DL
    Pediatr Nephrol; 2003 Nov; 18(11):1172-6. PubMed ID: 12920629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adolescent hemodialysis: results of the 2000 ESRD Clinical Performance Measures Project.
    Frankenfield DL; Neu AM; Warady BA; Watkins SL; Friedman AL; Fivush BA
    Pediatr Nephrol; 2002 Jan; 17(1):10-5. PubMed ID: 11793128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anemia management of adult hemodialysis patients in the US results: from the 1997 ESRD Core Indicators Project.
    Frankenfield D; Johnson CA; Wish JB; Rocco MV; Madore F; Owen WF
    Kidney Int; 2000 Feb; 57(2):578-89. PubMed ID: 10652035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemoglobin response and influence on left ventricular hypertrophy after 24-week treatment of a biosimilar epoetin-alfa in hemodialysis patients with anemia.
    Thanakitcharu P; Siriwiwatanakul N
    J Med Assoc Thai; 2007 Dec; 90(12):2574-86. PubMed ID: 18386706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anemia in pediatric hemodialysis patients: results from the 2001 ESRD Clinical Performance Measures Project.
    Frankenfield DL; Neu AM; Warady BA; Fivush BA; Johnson CA; Brem AS
    Kidney Int; 2003 Sep; 64(3):1120-4. PubMed ID: 12911565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anemia management and treatment response in patients on hemodialysis: the MAR study.
    Portolés J; López-Gómez JM; Aljama P
    J Nephrol; 2006; 19(3):352-60. PubMed ID: 16874697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Children on long-term dialysis in the United States: findings from the 2005 ESRD clinical performance measures project.
    Fadrowski JJ; Frankenfield D; Amaral S; Brady T; Gorman GH; Warady B; Furth SL; Fivush B; Neu AM
    Am J Kidney Dis; 2007 Dec; 50(6):958-66. PubMed ID: 18037097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced responsiveness to epoetin at re-exposure after prolonged epoetin-free period in anemic hemodialysis patients with end-stage renal disease.
    Milutinović S; Trkulja V
    Croat Med J; 2006 Jun; 47(3):424-32. PubMed ID: 16758521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of care assessment and adherence to the international guidelines considering dialysis, water treatment, and protection against transmission of infections in university hospital-based dialysis units in Cairo, Egypt.
    Ibrahim S
    Hemodial Int; 2010 Jan; 14(1):61-7. PubMed ID: 19758297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of single-pool and equilibrated Kt/V values for pediatric hemodialysis prescription management: analysis from the Centers for Medicare & Medicaid Services Clinical Performance Measures Project.
    Goldstein SL; Brem A; Warady BA; Fivush B; Frankenfield D
    Pediatr Nephrol; 2006 Aug; 21(8):1161-6. PubMed ID: 16705459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship among catheter insertions, vascular access infections, and anemia management in hemodialysis patients.
    Roberts TL; Obrador GT; St Peter WL; Pereira BJ; Collins AJ
    Kidney Int; 2004 Dec; 66(6):2429-36. PubMed ID: 15569336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epoetin requirement does not depend on dialysis dose when Kt/N > 1.33 in patients on regular dialysis treatment with cellulosic membranes and adequate iron stores.
    Movilli E; Cancarini GC; Vizzardi V; Camerini C; Brunori G; Cassamali S; Maiorca R
    J Nephrol; 2003; 16(4):546-51. PubMed ID: 14696757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anemia management with darbepoetin-alfa in outpatient hemodialysis patients switched from epoetin-alfa: a community hospital experience.
    Agrawal V; Mukherjee S; Kosuri R; Dumler F
    Am J Ther; 2010; 17(5):469-75. PubMed ID: 19770634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Erythropoietin Dose and Route of Administration with Clinical Outcomes for Patients on Hemodialysis in the United States.
    Wright DG; Wright EC; Narva AS; Noguchi CT; Eggers PW
    Clin J Am Soc Nephrol; 2015 Oct; 10(10):1822-30. PubMed ID: 26358266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth in adolescent hemodialysis patients: data from the Centers for Medicare & Medicaid Services ESRD Clinical Performance Measures Project.
    Neu AM; Bedinger M; Fivush BA; Warady BA; Watkins SL; Friedman AL; Brem AS; Goldstein SL; Frankenfield DL
    Pediatr Nephrol; 2005 Aug; 20(8):1156-60. PubMed ID: 15977027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes and dialysis adequacy in adolescent hemodialysis patients.
    Gorman G; Furth S; Hwang W; Parekh R; Astor B; Fivush B; Frankenfield D; Neu A
    Am J Kidney Dis; 2006 Feb; 47(2):285-93. PubMed ID: 16431257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients started on hemodialysis with tunneled dialysis catheter have similar survival after arteriovenous fistula and arteriovenous graft creation.
    Yuo TH; Chaer RA; Dillavou ED; Leers SA; Makaroun MS
    J Vasc Surg; 2015 Dec; 62(6):1590-7.e2. PubMed ID: 26372193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.
    Ifudu O; Feldman J; Friedman EA
    N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.